Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB2008

Introduced
6/10/25  

Caption

Stop Funding Genital Mutilation Act

Impact

If SB2008 is enacted, it would significantly alter the landscape of healthcare funding for transgender individuals, especially minors. The prohibition on Medicaid and CHIP funding for these procedures may limit access to necessary medical care for this population, reinforcing barriers for transgender youth and their families seeking medical support. The bill could lead to increased financial burdens on families, forcing them to pay for these procedures out-of-pocket or forgoing them entirely. Moreover, the bill may have broader implications for the interpretation of gender identity within federal healthcare policy, potentially influencing state-level decisions and funding as well.

Summary

SB2008, titled the 'Stop Funding Genital Mutilation Act', seeks to amend Title XIX of the Social Security Act by prohibiting Medicaid and CHIP from funding gender transition procedures. The bill lists various medical procedures that would fall under the prohibition, including surgeries such as castration and sterilization, as well as hormone therapies that are used for gender transition. Its primary objective is to restrict federal funding for specific medical services related to gender identity and transition, aimed particularly at minors.

Conclusion

In summary, SB2008 presents a critical juncture in the ongoing dialogue surrounding gender identity, healthcare access, and minors’ rights. If passed, it would impose federal restrictions that could reshape the medical landscape for transgender individuals, invoking issues of health equity and personal autonomy. As the bill progresses, it will likely continue to face fierce opposition and scrutiny on both ethical and health-related grounds.

Contention

The introduction of SB2008 has sparked considerable debate and contention among lawmakers and advocacy groups. Proponents argue that the bill protects minors from undergoing irreversible procedures they may later regret, asserting the need for more oversight in medical treatments related to gender transitioning. Opponents, including numerous health and civil rights organizations, criticize the bill as discriminatory, arguing it undermines the rights to healthcare access and dignity for transgender individuals. They highlight that medically necessary treatments should not be denied based on gender identity, rather advocating for supportive healthcare environments that are inclusive of all individuals.

Companion Bills

US HB1

Related FEHB Protection Act of 2025

Previously Filed As

US HB9874

Childhood Genital Mutilation Prevention Act

US SB5424

STOP Act Safeguarding The Overall Protection of Minors Act

US HB10172

Prohibition of Medicaid Funding for Conversion Therapy Act

US SB5333

Stop Wall Street Looting Act

US SB1595

End Taxpayer Funding of Gender Experimentation Act of 2023

US HB9679

SAFE Lending Act of 2024 Stopping Abuse and Fraud in Electronic Lending Act of 2024

US HB3329

End Taxpayer Funding of Gender Experimentation Act of 2023

US HB9937

Stop Predatory Investing Act

US HB8128

Access to Scalp Cooling Therapy Act of 2024

US SB4277

BUILD GREEN Infrastructure and Jobs Act Better Utilizing Investments to Leverage Development and Generating Renewable Energy to Electrify the Nation's Infrastructure and Jobs Act

Similar Bills

CA SB612

Speech-language pathologists.

CA SB277

Criminal procedure: search of persons.

US SB1551

No Subsidies for Gender Transition Procedures Act

US HB3205

No Subsidies for Gender Transition Procedures Act

CA SB1477

Enforcement of judgments: wage garnishment.

MD SB891

Public Health - Medical Procedures - Parent or Guardian Notice (Maryland Parental Involvement Enhancement Act)

CA AB392

Clinical laboratories: total protein test: authorization.

CA AB1069

Radiologic technologists: venipuncture: supervision.